Home › Schizophrenia
Pag-aaral pangklinika para sa Schizophrenia na nagre-recruit sa U.S.
105 pag-aaral para sa Schizophrenia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Atlanta, GA21 pag-aaral
- Chicago, IL20 pag-aaral
- Little Rock, AR18 pag-aaral
- San Diego, CA15 pag-aaral
- Houston, TX14 pag-aaral
- Boston, MA14 pag-aaral
- Hollywood, FL14 pag-aaral
- Hialeah, FL13 pag-aaral
- Austin, TX12 pag-aaral
- Garden Grove, CA12 pag-aaral
- New York City, NY12 pag-aaral
- Miami, FL10 pag-aaral
- Germantown, MD10 pag-aaral
- Richardson, TX9 pag-aaral
- Camden, NJ9 pag-aaral
- Cincinnati, OH8 pag-aaral
- Philadelphia, PA8 pag-aaral
- Anaheim, CA8 pag-aaral
- Cambridge, MA8 pag-aaral
- Springdale, AR8 pag-aaral
- Inglewood, CA8 pag-aaral
- Los Angeles, CA8 pag-aaral
- St. Louis, MO8 pag-aaral
- Grand Prairie, TX8 pag-aaral
- Johns Creek, GA8 pag-aaral
- Dallas, TX7 pag-aaral
- Las Vegas, NV7 pag-aaral
- Staten Island, NY7 pag-aaral
- Queens, NY7 pag-aaral
- Orange, CA7 pag-aaral
- El Cajon, CA7 pag-aaral
- Torrance, CA7 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Nashville, TN6 pag-aaral
- Richmond, VA6 pag-aaral
- Chino, CA6 pag-aaral
- Orlando, FL6 pag-aaral
- Oceanside, CA6 pag-aaral
- Downey, CA6 pag-aaral
- Riverside, CA6 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona4 pag-aaral
- Arkansas21 pag-aaral
- California45 pag-aaral
- Connecticut9 pag-aaral
- Florida25 pag-aaral
- Georgia28 pag-aaral
- Illinois25 pag-aaral
- Maryland18 pag-aaral
- Massachusetts23 pag-aaral
- Michigan4 pag-aaral
- Minnesota6 pag-aaral
- Mississippi4 pag-aaral
- Missouri11 pag-aaral
- Nebraska6 pag-aaral
- Nevada7 pag-aaral
- New Jersey13 pag-aaral
- New York22 pag-aaral
- North Carolina4 pag-aaral
- Ohio16 pag-aaral
- Oklahoma4 pag-aaral
- Pennsylvania15 pag-aaral
- Tennessee6 pag-aaral
- Texas33 pag-aaral
- Virginia6 pag-aaral
- Washington8 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Nagre-recruitPhase 3
Edad 13 hanggang 17 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07288567A Study to Evaluate the Effect of KarXT on Urological Safety
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07221877Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia
Nagre-recruitPhase 2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07592169A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07908680Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07853807Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07900893A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07424404REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
Nagre-recruit
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07006935Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06229210A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07615426Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07379827Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07686263Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07680946Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
Nagre-recruit
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05389787The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 45 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06386588A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07459647iTBS to Enhance Social Cognition in People With Psychosis
Nagre-recruit
Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT06118268A Study of Brenipatide in Adult Participants With Schizophrenia
Nagre-recruitPhase 2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT07410507Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05491538Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Nagre-recruitPhase 4
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05648591Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07680114Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06835556Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07101094Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07227818NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07105098Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.